How should I evaluate a cancer patient presenting with epistaxis?

Evaluation of Epistaxis in Cancer Patients

In a cancer patient with epistaxis, immediately perform anterior rhinoscopy to visualize the nasal cavity, and strongly consider nasal endoscopy—especially if the bleeding is recurrent, unilateral, or difficult to control—because underlying malignancy (recurrence, new primary tumor, or treatment-related vascular injury) must be ruled out. 1

Initial Assessment Priority

Your evaluation must focus on identifying life-threatening causes and excluding malignant pathology:

Key Historical Red Flags to Elicit:

• Unilateral bleeding (suggests tumor, foreign body, or vascular lesion)
• Recurrent episodes despite prior treatment
• History of head/neck radiation (risk of carotid blowout syndrome—potentially fatal) 2, 3
• Severity assessment: quantify bleeding volume, frequency, and whether it required packing/cautery previously
• Cancer-specific factors: primary tumor location (especially nasopharyngeal), prior radiation fields, current disease status
• Anticoagulation/antiplatelet medications and bleeding disorders
• Associated symptoms: nasal obstruction, pain, cranial nerve deficits, or neurologic symptoms 4

Physical Examination Algorithm:

1. Anterior rhinoscopy (mandatory first step) 1:

   • Remove blood clots by suction or gentle nose blowing to identify bleeding site
   • Look for visible masses, septal deviation, perforation, or mucosal abnormalities
   • Can use otoscope in children

2. Nasal endoscopy indications (perform or refer urgently) 1:

   • Recurrent epistaxis despite packing/cautery (STRONG indication)
   • Recurrent unilateral bleeding (STRONG indication—malignancy until proven otherwise)
   • Difficult to control bleeding
   • Any concern for underlying pathology in cancer patients
   • Allows examination of posterior nasal cavity and nasopharynx where malignancies may hide

Cancer-Specific Considerations

High-Risk Scenarios Requiring Immediate Advanced Evaluation:

Nasopharyngeal carcinoma patients 2, 5:

• Epistaxis after radiotherapy can herald carotid blowout syndrome (high mortality)
• Internal carotid artery (ICA) exposure is life-threatening
• Massive epistaxis (>500mL or requiring transfusion) requires emergency intervention
• Consider CT angiography if massive bleeding or recurrent episodes

Head and neck cancer survivors 6, 4:

• Epistaxis may indicate local recurrence or second primary tumor
• Even resolved epistaxis warrants investigation—can signal serious pathology like brain abscess or meningitis
• Low threshold for neuroimaging (CT/MRI) in this population

Patients on bevacizumab or other anti-angiogenic agents 7:

• Can cause severe (grade 4) epistaxis
• May require drug discontinuation

When to Order Imaging:

CT scan indications 8:

• Recurrent epistaxis
• Severe or posterior bleeding
• Suspected structural abnormality or tumor
• Pre-operative planning

CT angiography 2, 5, 8:

• Massive epistaxis in radiated patients (rule out pseudoaneurysm/carotid involvement)
• Recurrent severe bleeding
• Planning for interventional procedures

MRI 8:

• Suspected soft tissue extension
• Intracranial involvement concern
• Complement to CT when tumor suspected

Critical Pitfalls to Avoid:

1. Never assume benign etiology in cancer patients—malignancy incidence is 0.43% in general epistaxis patients but significantly higher in cancer populations 9

2. Don't delay endoscopy for recurrent or unilateral bleeding—anterior rhinoscopy alone misses posterior/nasopharyngeal pathology 1

3. Recognize carotid blowout urgency in radiated patients—this is a surgical/interventional emergency requiring immediate ENT and interventional radiology consultation 2, 3, 5

4. Document thoroughly for medicolegal purposes and to guide follow-up 1

Follow-Up Requirements:

• Routine follow-up mandatory after any invasive treatment 1
• Adequate follow-up allows assessment for treatment failure or recurrent bleeding that may indicate underlying conditions like hematologic malignancies or intranasal tumors 1
• Educate patients about warning signs requiring immediate return: persistent obstruction, severe pain, neurologic symptoms

Bottom Line Algorithm:

1. History: Focus on unilateral/recurrent pattern, radiation history, cancer status, severity
2. Anterior rhinoscopy: Always perform first
3. Nasal endoscopy: Low threshold in cancer patients, mandatory if recurrent/unilateral/difficult to control
4. Imaging: CT/CTA for severe, recurrent, or post-radiation cases
5. Urgent ENT referral: If mass identified, massive bleeding, or radiated patient with recurrent episodes

The incidence of neoplasm requiring further workup is 3.09% in general epistaxis populations 9, but your cancer patient has substantially elevated risk warranting aggressive evaluation.